BrainsWay

Headquarters:

Investor Relations:

Description

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy.

Industry

Medical Devices

Year Founded

Website

Ownership

Public

Exchange / Symbol

NASDAQ / BWAY

Public Since

Chief Executive Officer

Chairman of the Board

Chief Financial Officer

Insider Ownership

Key Investors

Employee Count

Auditors

Investment Bankers

Law Firms

In the CEOs Own Words

Corporate Mission

Proudest Accomplishment

Next Milestone

Geographic Markets Served

Growth Drivers

Growth Headwinds

Indicia of Customer Satisfaction

Scalability

Workforce

Focus of Recruitment

Research and Development

Patent Count

Economic Sensitivity

Unique Metrics

Greatest Concern

Company Reports and Communications

Company Press Releases

SEC Filings

" target="_blank">

Solution Nation Reports

Solution Nation Podcasts

Open Questions to Management

Chatboard

Yahoo Finance

Yahoo Finance